After teaming up with GlaxoSmithKline and Dynavax early on in the pandemic, Chinese biotech Clover Biopharmaceuticals has started trials of its COVID-19 vaccine and expects data in August.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,